ETV3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.08070000515559E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.009204162576E-11 |
Normal-vs-Stage2 |
5.60819999995132E-07 |
Normal-vs-Stage3 |
3.003500E-04 |
Normal-vs-Stage4 |
1.785540E-04 |
Stage1-vs-Stage2 |
9.417200E-01 |
Stage1-vs-Stage3 |
1.570780E-01 |
Stage1-vs-Stage4 |
9.250800E-01 |
Stage2-vs-Stage3 |
3.008200E-01 |
Stage2-vs-Stage4 |
8.823600E-01 |
Stage3-vs-Stage4 |
4.208800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.95360402802203E-11 |
Normal-vs-AfricanAmerican |
2.25069995973826E-09 |
Normal-vs-Asian |
2.558800E-04 |
Caucasian-vs-AfricanAmerican |
8.907600E-01 |
Caucasian-vs-Asian |
4.383600E-01 |
AfricanAmerican-vs-Asian |
4.415800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.441590E-01 |
Male-vs-Female |
1.975700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.77822999999355E-05 |
Normal-vs-Extreme_Weight |
1.62547753035369E-12 |
Normal-vs-Obese |
1.24719999994305E-07 |
Normal-vs-Extreme_Obese |
1.75840000005145E-06 |
Normal_Weight-vs-Extreme_Weight |
8.862300E-02 |
Normal_Weight-vs-Obese |
7.833000E-01 |
Normal_Weight-vs-Extreme_Obese |
1.171040E-01 |
Extreme_Weight-vs-Obese |
5.979800E-03 |
Extreme_Weight-vs-Extreme_Obese |
8.607600E-01 |
Obese-vs-Extreme_Obese |
3.443800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.124320E-02 |
Normal-vs-Age(41-60Yrs) |
9.26499998943342E-09 |
Normal-vs-Age(61-80Yrs) |
1.50990331349021E-13 |
Normal-vs-Age(81-100Yrs) |
1.28860000447872E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.523400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816570E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.692100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.964410E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.976500E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.625800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62525548574877E-12 |
Normal-VS-Type2 PRCC |
1.56880000101722E-08 |
Normal-VS-KIRP CIMP |
3.977000E-01 |
Normal-VS-Unclassified PRCC |
7.96980000000724E-05 |
Type1 PRCC-VS-Type2 PRCC |
9.685500E-02 |
Type1 PRCC-VS-KIRP CIMP |
6.682300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
9.195500E-03 |
Type2 PRCC-VS-KIRP CIMP |
1.368760E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.866000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.673560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.24775794935795E-12 |
Normal-vs-N1 |
3.776000E-03 |
Normal-vs-N2 |
2.834000E-02 |
N0-vs-N1 |
4.726100E-02 |
N0-vs-N2 |
3.911000E-01 |
N1-vs-N2 |
7.383400E-01 |
|
|